Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma - European Journal of Cancer
Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic Markers | Clinical Cancer Research
Descriptive and prognostic value of a computational model of metastasis in high-risk neuroblastoma | medRxiv
Neuroblastoma in Vietnam: A retrospective analysis of MYCN status and clinical features to inform prognosis and improve outcome
A deeper look at the recent DFMO paper... - Beat Childhood Cancer
Figure 5 | Incidence, Survival, and Treatment of Localized and Metastatic Neuroblastoma in Germany 1979–2015 | SpringerLink
Clinico-epidemiology of neuroblastoma in north east Egypt: A 5-year multicenter study
Overall survival of the neuroblastoma patients in correlation with the... | Download Scientific Diagram
Age is associated with the overall survival of pediatric neuroblastoma... | Download Scientific Diagram
The 3-year overall survival for transplanted high-risk neuroblastoma. | Download Scientific Diagram
Is the prognosis of stage 4s neuroblastoma in patients 12 months of age and older really excellent? - ScienceDirect
Neuroblastoma | Radiology Key
Figure 2 from Advances in Risk Classification and Treatment Strategies for Neuroblastoma. | Semantic Scholar
PLOS ONE: Serum-Based Quantification of MYCN Gene Amplification in Young Patients with Neuroblastoma: Potential Utility as a Surrogate Biomarker for Neuroblastoma
Overall survival of 500 neuroblastoma patients according to age at... | Download Scientific Diagram
Anti-GD2 immunotherapy for neuroblastoma. - Abstract - Europe PMC
A single center clinical analysis of children with neuroblastoma
Autotransplants for Neuroblastoma (Chapter 51) - Hematopoietic Cell Transplants
Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma - European Journal of Cancer
Neuroblastoma between 1990 and 2014 in the Netherlands: Increased incidence and improved survival of high-risk neuroblastoma - ScienceDirect
Deletion of 11q in Neuroblastomas Drives Sensitivity to PARP Inhibition | Clinical Cancer Research
Current and Future Strategies for Treatment of Relapsed Neuroblastoma | Neupsy Key
Unchanged incidence and increased survival in children with neuroblastoma in Denmark 1981–2000: a population-based study | British Journal of Cancer
Neuroblastoma in Vietnam: A retrospective analysis of MYCN status and clinical features to inform prognosis and improve outcome
Kaplan–Meier curves for neuroblastoma patients with and without TIAM1... | Download Scientific Diagram
Clinico-epidemiology of neuroblastoma in north east Egypt: A 5-year multicenter study
Clinical Features of Neuroblastoma with 11q Deletion: An Increase in Relapse Probabilities in Localized and 4S Stages | Scientific Reports
